[1] |
LI Yanyang, WANG Yunjiao, LV Shichao.
Effects and mechanism of traditional Chinese medicine injection in prevention and treatment of cardiotoxicity induced by antineoplastic drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 572-577.
|
[2] |
LI Ruoning, GUO Zhanli, WANG Yuan, SUN Jianjun.
Platelet-endothelial aggregation receptor 1 and its mediated signalling pathway Advances in the study of the role of platelets and endothelial cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 438-444.
|
[3] |
WANG Siyu, LI Jiawei, LI Chenghao, LI Ling, GUO Qingyang, QIU Lu, ZHOU Shiqin, LIU Yongqi.
Research progress of lactate dehydrogenase A in digestive system tumors and related drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 445-454.
|
[4] |
LI Shan, LIU Yixin, REN Feifei, LI Xiangchen, ZHANG Zhiqing.
Research progress of natural plant active ingredients in reversing tumor multidrug resistance by down-regulating P-gp
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 331-340.
|
[5] |
WANG Dan, YAN Xiaoli, ZHANG Yuan.
Helicobacter pylori infection influences the efficacy of immunotherapies for gastric cancer#br#
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 228-234.
|
[6] |
ZHANG Wei, WANG Hongyuan, LEI Xiaohang, ZHAO Yingshuai, LV Weichao, ZHANG Jianguo.
BCG + piroxicam versus BCG + gemcitabine for prevention of postoperative recurrence in intermediate- and high-risk bladder cancer and effects on serum AGR and PON1
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1146-1153.
|
[7] |
LIU Dan, LIU Ming, JIN Liangyou, PAN Juan, XIN Haoru, LIU Mengyuan, LI Xin, ZHENG Kun, FENG Xiaoling.
Research progress on the antitumor activity of costunolide
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1168-1176.
|
[8] |
LIU Jiajun, QUE Zujun, TIAN Jianhui.
Comparative study on the ability of active ingredients in Jinfukang to decrease neutrophils recruiting by lung cancer circulating tumor cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 1-9.
|
[9] |
HUANG Hao, JIA Hong, WANG Xiaoshuang, ZHANG Lu, JIANG Hua.
Effects of co-culture of dendritic cells loaded with MAGE-A3 antigen and cytokine-induced killer cells on tumor stem cells and malignant progression of endometrial cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 42-50.
|
[10] |
GAO Lili, WANG Yuzhu, WANG Yan, LI Jian, WANG Jun.
General considerations for clinical pharmacology of antitumor antibody-conjugated drugs: Implications from FDA review cases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 75-85.
|
[11] |
LIU Jiajia, GAO Yan, ZHANG Yehui, WU Jing.
Functions of CRABP2 in tumorigenesis and progression
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 86-92.
|
[12] |
HONG Ziqiang, GOU Wenxi, CUI Baiqiang, BAI Xiangdou, JIN Dacheng, GOU Yunjiu.
Role of the m7G methyltransferase METTL1 in tumours
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 93-100.
|
[13] |
WANG Yali, HUO Xulei, CHEN Feng, LI Shenglan, ZHENG Xiaohong, WANG Can, LI Wenbin.
Research progress on the antitumor effect of nifurtimox
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 955-960.
|
[14] |
SHI Jingbin, XIONG Yang.
Research progress on interaction between tumor microenvironment and breast cancer cells leading to tumor metastasis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(5): 562-574.
|
[15] |
MA Wangbo, Ma Yue, FAN Fangtian, ZHANG Yuhan, CHANG Jingwen, ZHOU Zhihua.
Effects of Shenqi fuzheng injection on low-glucose-mediated immunosuppressive microenvironment and its mechanism of action
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(2): 136-143.
|